Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 167868, 12 pages
http://dx.doi.org/10.1155/2012/167868
Review Article

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status

1Liver Unit, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada H2X 3J4
2Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

Received 17 April 2012; Accepted 18 May 2012

Academic Editor: Averell Sherker

Copyright © 2012 Gilles Pomier-Layrargues et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Sanyal, J. Bosch, A. Blei, and V. Arroyo, “Portal hypertension and its complications,” Gastroenterology, vol. 134, no. 6, pp. 1715–1728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Rösch, W. N. Hanafe, and H. Snow, “Transjugular portal venography and radiologic portacaval shunt: an experimental study,” Radiology, vol. 92, no. 5, pp. 1112–1114, 1969. View at Google Scholar · View at Scopus
  3. R. F. Colapinto, R. D. Stronell, S. J. Birch et al., “Creation of an intrahepatic portosystemic shunt with a Gruntzig balloon catheter,” Canadian Medical Association Journal, vol. 126, no. 3, pp. 267–268, 1982. View at Google Scholar · View at Scopus
  4. M. Rössle, G. M. Richter, G. Noldge, J. C. Palmaz, W. Wenz, and W. Gerok, “New non-operative treatment for variceal haemorrhage,” The Lancet, vol. 2, no. 8655, p. 153, 1989. View at Google Scholar · View at Scopus
  5. T. D. Boyer and Z. J. Haskal, “The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009,” Hepatology, vol. 51, no. 1, pp. 1–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Hassoun and G. Pomier-Layrargues, “The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension,” European Journal of Gastroenterology and Hepatology, vol. 16, no. 1, pp. 1–4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Degasperi, A. Corti, R. Corso et al., “Transjugular intrahepatic portosystemic shunt (TIPS): the anesthesiological point of view after 150 procedures managed under total intravenous anesthesia,” Journal of Clinical Monitoring and Computing, vol. 23, no. 6, pp. 341–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Easa and T. Clark, “Transjugular intrahepatic portosystemic shunt: state of the art,” Seminars in Roentgenology, vol. 46, no. 2, pp. 125–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Casado, J. Bosch, J. C. Garcia-Pagan et al., “Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings,” Gastroenterology, vol. 114, no. 6, pp. 1296–1303, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Scanlon and R. K. Ryu, “Portal vein imaging and access for transjugular intrahepatic portosystemic shunts,” Techniques in Vascular and Interventional Radiology, vol. 11, no. 4, pp. 217–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Angermayr, M. Cejna, F. Koenig et al., “Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents,” Hepatology, vol. 38, no. 4, pp. 1043–1050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Bureau, J. C. G. Pagan, G. P. Layrargues et al., “Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study,” Liver International, vol. 27, no. 6, pp. 742–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Cejna, M. Peck-Radosavljevic, S. A. Thurnher, K. Hittmair, M. Schoder, and J. Lammer, “Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis,” Radiology, vol. 221, no. 2, pp. 437–446, 2001. View at Google Scholar · View at Scopus
  14. G. P. Guerrini, M. Pleguezuelo, S. Maimone et al., “Impact of tips preliver transplantation for the outcome posttransplantation,” American Journal of Transplantation, vol. 9, no. 1, pp. 192–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Tripathi, G. Therapondos, D. N. Redhead, K. K. Madhavan, and P. C. Hayes, “Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation,” European Journal of Gastroenterology and Hepatology, vol. 14, no. 8, pp. 827–832, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. A. Colombato, L. Spahr, J. P. Martinet et al., “Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients,” Gut, vol. 39, no. 4, pp. 600–604, 1996. View at Google Scholar · View at Scopus
  17. M. Merli, V. Valeriano, S. Funaro et al., “Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (tips),” American Journal of Gastroenterology, vol. 97, no. 1, pp. 142–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Fanelli, S. Angeloni, F. M. Salvatori et al., “Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma,” Digestive and Liver Disease, vol. 43, no. 1, pp. 78–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Han, X. Qi, C. He et al., “Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis,” Journal of Hepatology, vol. 54, no. 1, pp. 78–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Senzolo, P. Burra, D. Patch, and A. K. Burroughs, “Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe,” Journal of Hepatology, vol. 55, no. 4, pp. 945–946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Wils, E. Van Der Linden, B. Van Hoek, and P. M. T. Pattynama, “Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation,” Journal of Clinical Gastroenterology, vol. 43, no. 10, pp. 982–984, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Chalasani, W. S. Clark, L. G. Martin et al., “Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting,” Gastroenterology, vol. 118, no. 1, pp. 138–144, 2000. View at Google Scholar · View at Scopus
  23. D. Patch, V. Nikolopoulou, A. McCormick et al., “Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding,” Journal of Hepatology, vol. 28, no. 3, pp. 454–460, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. S. S. Rouillard, N. M. Bass, J. P. Roberts et al., “Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome,” Annals of Internal Medicine, vol. 128, no. 5, pp. 374–377, 1998. View at Google Scholar · View at Scopus
  25. M. Malinchoc, P. S. Kamath, F. D. Gordon, C. J. Peine, J. Rank, and P. C. Ter Borg, “A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts,” Hepatology, vol. 31, no. 4, pp. 864–871, 2000. View at Google Scholar · View at Scopus
  26. F. Salerno, M. Merli, M. Cazzaniga et al., “MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt,” Journal of Hepatology, vol. 36, no. 4, pp. 494–500, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Schepke, F. Roth, R. Fimmers et al., “Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting,” American Journal of Gastroenterology, vol. 98, no. 5, pp. 1167–1174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. R. C. Gaba, V. L. Khiatani, M. G. Knuttinen et al., “Comprehensive review of TIPS technical complications and how to avoid them,” American Journal of Roentgenology, vol. 196, no. 3, pp. 675–685, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Freedman, A. J. Sanyal, J. Tisnado et al., “Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review,” Radiographics, vol. 13, no. 6, pp. 1185–1210, 1993. View at Google Scholar · View at Scopus
  30. S. Mallery, M. L. Freeman, C. J. Peine, R. P. Miller, and W. R. Stanchfield, “Biliary-shunt fistula following transjugular intrahepatic portosystemic shunt placement,” Gastroenterology, vol. 111, no. 5, pp. 1353–1357, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Spahr, A. Sahai, R. Lahaie et al., “Transient healing of TIPS-induced biliovenous fistula by PTFE-covered stent graft,” Digestive Diseases and Sciences, vol. 41, no. 11, pp. 2229–2232, 1996. View at Google Scholar · View at Scopus
  32. H. O. Conn, “Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome,” Hepatology, vol. 23, no. 1, pp. 177–181, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. A. J. Sanyal, A. M. Freedman, P. P. Purdum, M. L. Shiffman, and V. A. Luketic, “The hematologic consequences of transjugular intrahepatic portosystemic shunts,” Hepatology, vol. 23, no. 1, pp. 32–39, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Bureau, P. Otal, V. Chabbert, J. M. Péron, H. Rousseau, and J. P. Vinel, “Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent,” Hepatology, vol. 36, no. 6, p. 1554, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ditisheim, M. P. Sylvestre, L. Bouchard et al., “Transient segmental hepatic ischemia following PTFE-coated TIPS stent implantation does not influence the clinical outcome in cirrhotic patients,” Gastroenterology, vol. 142, no. 5, Supplement, p. S946, 2012. View at Google Scholar
  36. R. Jalan, D. J. Harrison, D. N. Redhead, and P. C. Hayes, “Transjugular intrahepatic portosystemic stent-shunt (TIFSS) occlusion and the role of biliary venous fistulae,” Journal of Hepatology, vol. 24, no. 2, pp. 169–176, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. R. R. Saxon, J. Mendel-Hartvig, C. L. Corless et al., “Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine,” Journal of Vascular and Interventional Radiology, vol. 7, no. 4, pp. 487–497, 1996. View at Google Scholar · View at Scopus
  38. P. Sauer, L. Theilmann, S. Herrmann et al., “Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial,” Hepatology, vol. 24, no. 6, pp. 1433–1436, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. J. Haskal, M. J. Pentecost, and R. A. Rubin, “Hepatic arterial injury after transjugular intrahepatic portosystemic shunt placement: report of two cases,” Radiology, vol. 188, no. 1, pp. 85–88, 1993. View at Google Scholar · View at Scopus
  40. P. M. T. Pattynama, B. van Hoek, and L. J. S. Kool, “Inadvertent arteriovenous stenting during transjugular intrahepatic portosystemic shunt procedure and the importance of hepatic artery perfusion,” CardioVascular and Interventional Radiology, vol. 18, no. 3, pp. 192–195, 1995. View at Google Scholar · View at Scopus
  41. M. Bai, X. Qi, Z. Yang et al., “Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review,” Journal of Gastroenterology and Hepatology, vol. 26, no. 6, pp. 943–951, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Guevara, M. E. Baccaro, J. Rios et al., “Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration,” Liver International, vol. 30, no. 8, pp. 1137–1142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Hassoun, M. Deschenes, M. Lafortune et al., “Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy,” American Journal of Gastroenterology, vol. 96, no. 4, pp. 1205–1209, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Jalan, R. A. Elton, D. N. Redhead, N. D. C. Finlayson, and P. C. Hayes, “Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage,” Journal of Hepatology, vol. 23, no. 2, pp. 123–128, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Nolte, J. Wiltfang, C. Schindler et al., “Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations,” Hepatology, vol. 28, no. 5, pp. 1215–1225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Riggio, S. Angeloni, F. M. Salvatori et al., “Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts,” American Journal of Gastroenterology, vol. 103, no. 11, pp. 2738–2746, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. O. Riggio, L. Ridola, S. Angeloni et al., “Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial,” Journal of Hepatology, vol. 53, no. 2, pp. 267–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. J. Sanyal, A. M. Freedman, M. L. Shiffman, P. P. Purdum, V. A. Luketic, and A. K. Cheatham, “Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study,” Hepatology, vol. 20, no. 1 I, pp. 46–55, 1994. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Masson, H. A. Mardini, J. D. Rose, and C. O. Record, “Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience,” Journal of the Association of Physicians, vol. 101, no. 6, pp. 493–501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Riggio, A. Masini, C. Efrati et al., “Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study,” Journal of Hepatology, vol. 42, no. 5, pp. 674–679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. R. K. Kerlan Jr., J. M. LaBerge, E. L. Baker et al., “Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts,” Journal of Vascular and Interventional Radiology, vol. 6, no. 6, pp. 917–921, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Lafortune, J. P. Martinet, A. Denys et al., “Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study,” American Journal of Roentgenology, vol. 164, no. 4, pp. 997–1002, 1995. View at Google Scholar · View at Scopus
  53. J. Žižka, P. Eliáš, A. Krajina et al., “Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients,” American Journal of Roentgenology, vol. 175, no. 1, pp. 141–148, 2000. View at Google Scholar · View at Scopus
  54. H. Ducoin, J. El-Khoury, H. Rousseau et al., “Histopathologic analysis of transjugular intrahepatic portosystemic shunts,” Hepatology, vol. 25, no. 5, pp. 1064–1069, 1997. View at Google Scholar · View at Scopus
  55. L. Theilmann, P. Sauer, T. Roeren et al., “Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portal-systemic stent shunts: a controlled study,” Hepatology, vol. 20, no. 3, pp. 592–597, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. V. Siegerstetter, M. Huber, A. Ochs, H. E. Blum, and M. Rössle, “Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment,” Hepatology, vol. 29, no. 1, pp. 33–38, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. P. K. Armstrong and C. MacLeod, “Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature,” Clinical Infectious Diseases, vol. 36, no. 4, pp. 407–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Mizrahi, T. Adar, D. Shouval, A. I. Bloom, and O. Shibolet, “Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management,” Liver International, vol. 30, no. 2, pp. 175–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Zheng, Y. Chen, J. Bai et al., “Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update,” Journal of Clinical Gastroenterology, vol. 42, no. 5, pp. 507–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. H. O. Conn, W. W. Lindenmuth, C. J. May, and G. R. Ramsby, “Prophylactic portacaval anastomosis,” Medicine, vol. 51, no. 1, pp. 27–40, 1972. View at Google Scholar · View at Scopus
  61. D. Azoulay, D. Castaing, P. Majno et al., “Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis,” Journal of Hepatology, vol. 35, no. 5, pp. 590–597, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. G. D'Amico and A. Luca, “TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varices,” Journal of Hepatology, vol. 48, no. 3, pp. 387–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. A. J. Sanyal, A. M. Freedman, V. A. Luketic et al., “Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy,” Gastroenterology, vol. 111, no. 1, pp. 138–146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Vangeli, D. Patch, and A. K. Burroughs, “Salvage tips for uncontrolled variceal bleeding,” Journal of Hepatology, vol. 37, no. 5, pp. 703–704, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. J. C. García-Pagán, K. Caca, C. Bureau et al., “Early use of TIPS in patients with cirrhosis and variceal bleeding,” New England Journal of Medicine, vol. 362, no. 25, pp. 2370–2379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. J. P. Villeneuve, G. Pomier-Layrargues, L. Duguay et al., “Emergency portacaval shunt for variceal hemorrhage. a prospective study,” Annals of Surgery, vol. 206, no. 1, pp. 48–52, 1987. View at Google Scholar · View at Scopus
  67. Y. Narahara, H. Kanazawa, H. Kawamata et al., “A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage,” Hepatology Research, vol. 21, no. 3, pp. 189–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Sauer, J. Hansmann, G. M. Richter, W. Stremmel, and A. Stiehl, “Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial,” Endoscopy, vol. 34, no. 9, pp. 690–697, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Rössle, P. Deibert, K. Haag et al., “Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding,” The Lancet, vol. 349, no. 9058, pp. 1043–1049, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. J. P. Cello, E. J. Ring, E. W. Olcott et al., “Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial,” Annals of Internal Medicine, vol. 126, no. 11, pp. 858–865, 1997. View at Google Scholar · View at Scopus
  71. À. Escorsell, R. Bañares, J. C. García-Pagán et al., “TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial,” Hepatology, vol. 35, no. 2, pp. 385–392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. L. García-Villarreal, F. Martínez-Lagares, A. Sierra et al., “Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage,” Hepatology, vol. 29, no. 1, pp. 27–32, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. V. Gülberg, M. Schepke, G. Geigenberger et al., “Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial,” Scandinavian Journal of Gastroenterology, vol. 37, no. 3, pp. 338–343, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Jalan, E. H. Forrest, A. J. Stanley et al., “A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices,” Hepatology, vol. 26, no. 5, pp. 1115–1122, 1997. View at Google Scholar · View at Scopus
  75. M. Merli, F. Salerno, O. Riggio et al., “Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial,” Hepatology, vol. 27, no. 1, pp. 48–53, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Pomier-Layrargues, J. P. Villeneuve, M. Deschênes et al., “Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial,” Gut, vol. 48, no. 3, pp. 390–396, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Cabrera, M. Maynar, R. Granados et al., “Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage,” Gastroenterology, vol. 110, no. 3, pp. 832–839, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. A. J. Sanyal, A. M. Freedman, V. A. Luketic et al., “Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial,” Annals of Internal Medicine, vol. 126, no. 11, pp. 849–857, 1997. View at Google Scholar · View at Scopus
  79. G. V. Papatheodoridis, J. Goulis, G. Leandro, D. Patch, and A. K. Burroughs, “Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis,” Hepatology, vol. 30, no. 3, pp. 612–622, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. A. K. Burroughs and M. Vangeli, “Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis,” Scandinavian Journal of Gastroenterology, vol. 37, no. 3, pp. 249–252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Jalan, T. G. John, D. N. Redhead et al., “A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage,” American Journal of Gastroenterology, vol. 90, no. 11, pp. 1932–1937, 1995. View at Google Scholar · View at Scopus
  82. W. S. Helton, R. Maves, K. Wicks, and K. Johansen, “Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison,” Archives of Surgery, vol. 136, no. 1, pp. 17–20, 2001. View at Google Scholar · View at Scopus
  83. J. M. Henderson, T. D. Boyer, M. H. Kutner et al., “Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial,” Gastroenterology, vol. 130, no. 6, pp. 1643–1651, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Irani, K. Kowdley, and R. Kozarek, “Gastric varices: an updated review of management,” Journal of Clinical Gastroenterology, vol. 45, no. 2, pp. 133–148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Barange, J. M. Péron, K. Imani et al., “Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices,” Hepatology, vol. 30, no. 5, pp. 1139–1143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. T. N. Chau, D. Patch, Y. W. Chan, A. Nagral, R. Dick, and A. K. Burroughs, “'Salvage' transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding,” Gastroenterology, vol. 114, no. 5, pp. 981–987, 1998. View at Google Scholar · View at Scopus
  87. G. H. Lo, H. L. Liang, W. C. Chen et al., “A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding,” Endoscopy, vol. 39, no. 8, pp. 679–685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Spahr, M. P. Dufresne, B. T. Bui et al., “Efficacy of TIPS in the prevention of rebleeding from esophageal and fundal varices: a comparative study,” Hepatology, vol. 22, no. 4, Abstract A296, 1995. View at Google Scholar
  89. D. Tripathi, G. Therapondos, E. Jackson, D. N. Redhead, and P. C. Hayes, “The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations,” Gut, vol. 51, no. 2, pp. 270–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. I. K. Tesdal, T. Filser, C. Weiss, E. Holm, C. Dueber, and W. Jaschke, “Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding,” Radiology, vol. 236, no. 1, pp. 360–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Vangeli, D. Patch, N. Terreni et al., “Bleeding ectopic varices—treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation,” Journal of Hepatology, vol. 41, no. 4, pp. 560–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Vidal, L. Joly, P. Perreault, L. Bouchard, M. Lafortune, and G. Pomier-Layrargues, “Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients,” Cardiovascular and Interventional Radiology, vol. 29, no. 2, pp. 216–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. P. S. Kamath, M. Lacerda, D. A. Ahlquist, M. A. McKusick, J. C. Andrews, and D. A. Nagorney, “Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis,” Gastroenterology, vol. 118, no. 5, pp. 905–911, 2000. View at Google Scholar · View at Scopus
  94. L. Spahr, J. P. Villeneuve, M. P. Dufresne et al., “Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension,” Gut, vol. 44, no. 5, pp. 739–742, 1999. View at Google Scholar · View at Scopus
  95. C. Vincent, G. Pomier-Layrargues, M. Dagenais et al., “Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis,” Liver Transplantation, vol. 8, no. 8, pp. 717–720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. G. D'Amico, A. Luca, A. Morabito, R. Miraglia, and M. D'Amico, “Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis,” Gastroenterology, vol. 129, no. 4, pp. 1282–1293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. V. Arroyo, P. Ginès, A. L. Gerbes et al., “Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis,” Hepatology, vol. 23, no. 1, pp. 164–176, 1996. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Deschênes, M. P. Dufresne, B. Bui et al., “Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites,” American Journal of Gastroenterology, vol. 94, no. 5, pp. 1361–1365, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. J. P. Martinet, D. Fenyves, L. Legault et al., “Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). a caution,” Digestive Diseases and Sciences, vol. 42, no. 1, pp. 161–166, 1997. View at Publisher · View at Google Scholar · View at Scopus
  100. U. Thalheimer, G. Leandro, D. N. Samonakis et al., “TIPS for refractory ascites: a single-centre experience,” Journal of Gastroenterology, vol. 44, no. 10, pp. 1089–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Ginès, J. Uriz, B. Calahorra et al., “Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis,” Gastroenterology, vol. 123, no. 6, pp. 1839–1847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Lebrec, N. Giuily, A. Hadengue et al., “Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial,” Journal of Hepatology, vol. 25, no. 2, pp. 135–144, 1996. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Narahara, H. Kanazawa, T. Fukuda et al., “Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial,” Journal of Gastroenterology, vol. 46, no. 1, pp. 78–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Rössle, A. Ochs, V. Gülberg et al., “A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites,” New England Journal of Medicine, vol. 342, no. 23, pp. 1701–1707, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Salerno, M. Merli, O. Riggio et al., “Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites,” Hepatology, vol. 40, no. 3, pp. 629–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. A. J. Sanyal, C. Genning, K. R. Reddy et al., “The North American study for the treatment of refractory ascites,” Gastroenterology, vol. 124, no. 3, pp. 634–641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Albillos, R. Bañares, M. González, M. V. Catalina, and L. M. Molinero, “A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites,” Journal of Hepatology, vol. 43, no. 6, pp. 990–996, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. P. Deltenre, P. Mathurin, S. Dharancy et al., “Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis,” Liver International, vol. 25, no. 2, pp. 349–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. F. Salerno, C. Cammà, M. Enea, M. Rössle, and F. Wong, “Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data,” Gastroenterology, vol. 133, no. 3, pp. 825–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Ginès, P. Angeli, K. Lenz et al., “EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis,” Journal of Hepatology, vol. 53, no. 3, pp. 397–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. M. S. Campbell, C. M. Brensinger, A. J. Sanyal et al., “Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy,” Hepatology, vol. 42, no. 3, pp. 635–640, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. R. Dhanasekaran, J. K. West, P. C. Gonzales et al., “Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis,” American Journal of Gastroenterology, vol. 105, no. 3, pp. 635–641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. V. Siegerstetter, P. Deibert, A. Ochs, M. Olschewski, H. E. Blum, and M. Rössle, “Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients,” European Journal of Gastroenterology and Hepatology, vol. 13, no. 5, pp. 529–534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. F. D. Gordon, H. T. Anastopoulos, W. Crenshaw et al., “The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt,” Hepatology, vol. 25, no. 6, pp. 1366–1369, 1997. View at Publisher · View at Google Scholar · View at Scopus
  115. K. A. Brensing, J. Textor, J. Perz et al., “Long term outcome after transjugular intrahepatic portosystemic stent—shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study,” Gut, vol. 47, no. 2, pp. 288–295, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Guevara, P. Ginès, J. C. Bandi et al., “Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems,” Hepatology, vol. 28, no. 2, pp. 416–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  117. L. Spahr, D. Fenyves, V. V. N'Guyen et al., “Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt,” American Journal of Gastroenterology, vol. 90, no. 7, pp. 1169–1171, 1995. View at Google Scholar · View at Scopus
  118. T. Orug, Z. F. Soonawalla, K. Tekin, S. P. Olliff, J. A. C. Buckels, and A. D. Mayer, “Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation,” British Journal of Surgery, vol. 91, no. 6, pp. 769–773, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. J. C. Garcia-Pagán, M. Heydtmann, S. Raffa et al., “TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 Patients,” Gastroenterology, vol. 135, no. 3, pp. 808–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Perelló, J. C. García-Pagán, R. Gilabert et al., “TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy,” Hepatology, vol. 35, no. 1, pp. 132–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  121. M. W. Fried, D. G. Connaghan, S. Sharma et al., “Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation,” Hepatology, vol. 24, no. 3, pp. 588–591, 1996. View at Publisher · View at Google Scholar · View at Scopus
  122. F. O. Smith, M. S. Johnson, L. R. Scherer et al., “Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease,” Bone Marrow Transplantation, vol. 18, no. 3, pp. 643–646, 1996. View at Google Scholar · View at Scopus
  123. D. Azoulay, F. Buabse, I. Damiano et al., “Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension,” Journal of the American College of Surgeons, vol. 193, no. 1, pp. 46–51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. E. Vinet, P. Perreault, L. Bouchard et al., “Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study,” Canadian Journal of Gastroenterology, vol. 20, no. 6, pp. 401–404, 2006. View at Google Scholar · View at Scopus
  125. H. M. Lasch, M. W. Fried, S. L. Zacks et al., “Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome,” Liver Transplantation, vol. 7, no. 2, pp. 147–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  126. A. S. Paramesh, S. Z. Husain, B. Shneider et al., “Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature,” Pediatric Transplantation, vol. 7, no. 2, pp. 157–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. J. L. Riegler, K. A. Lang, S. P. Johnson, and J. H. Westerman, “Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome,” Gastroenterology, vol. 109, no. 3, pp. 978–983, 1995. View at Publisher · View at Google Scholar · View at Scopus
  128. O. Riggio, L. Ridola, C. Lucidi, and S. Angeloni, “Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?” Digestive and Liver Disease, vol. 42, no. 7, pp. 462–467, 2010. View at Publisher · View at Google Scholar · View at Scopus